Home LiteratureArticle Details
PMID: 6577434 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo.

Schulz G, Bumol TF, Reisfeld RA

Abstract

Monoclonal antibody 9.2.27 (mAb 9.2.27) directed to a chondroitin sulfate proteoglycan on human melanoma cells was able to suppress tumor growth in athymic (nu/nu) mice more effectively when bound with polyethylene glycol to murine effector cells than when injected alone. These "armed" effector cells also proved more effective than the monoclonal antibody in eliciting antibody-dependent cellular cytotoxicity against human melanoma target cells in vitro.

MeSH Terms
Animals Antibodies, Monoclonal/immunology Antibody-Dependent Cell Cytotoxicity Cell Line Flow Cytometry Humans Immunoglobulin G/immunology Immunotherapy Lymphocytes/immunology Melanoma/immunology,therapy Mice Mice, Inbred BALB C Mice, Nude Neoplasm Transplantation Pancreatic Neoplasms/immunology Receptors, Fc/immunology Transplantation, Heterologous
Chemicals
Antibodies, Monoclonal Immunoglobulin G Receptors, Fc
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Schulz G
Bumol T F
Reisfeld R A
References (23)
23 references, click to expand
  1. Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma.
    Blood. 1982 Jan;59(1):1-11 PMID: 7032624
  2. Production and characterization of monoclonal antibody to a melanoma specific glycoprotein.
    Hybridoma. 1981;1(1):27-36 PMID: 6208119
  3. Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours.
    Lancet. 1982 Apr 3;1(8275):762-5 PMID: 6121224
  4. Demonstration of antibodies against human malignant melanoma by immunofluorescence.
    Surgery. 1968 Jul;64(1):233-40 PMID: 4173159
  5. Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas.
    Int J Cancer. 1975 May 15;15(5):741-7 PMID: 1140870
  6. Production of melanoma-associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium.
    Cancer Res. 1976 Apr;36(4):1503-9 PMID: 1260767
  7. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.
    Immunochemistry. 1978 Jul;15(7):429-36 PMID: 30693
  8. Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma.
    Eur J Immunol. 1979 Aug;9(8):657-9 PMID: 499332
  9. Antibody-dependent cell-mediated cytolysis (ADCC) with antibody-coated effectors: new methods for enhancing antibody binding and cytolysis.
    J Immunol. 1980 Aug;125(2):926-33 PMID: 7391586
  10. New doxorubicin analogs active against doxorubicin-resistant colon tumor xenografts in the nude mouse.
    Cancer Res. 1980 Dec;40(12):4682-7 PMID: 7438099
  11. Macrophage-mediated, antibody-dependent destruction of tumor cells in DBA/2 mice: in vitro identification of an in situ mechanism.
    J Natl Cancer Inst. 1981 Jan;66(1):103-10 PMID: 7005500
  12. Normal levels of natural cytotoxic cells against solid tumours in NK-deficient beige mice.
    Nature. 1981 Mar 19;290(5803):254-7 PMID: 7207617
  13. Immunologic control of the ascites form of murine adenocarcinoma 755. V. Antibody-directed macrophages mediate tumor cell destruction.
    J Immunol. 1981 Jun;126(6):2337-41 PMID: 7229378
  14. Natural killer cells: their roles in defenses against disease.
    Science. 1981 Oct 2;214(4516):24-30 PMID: 7025208
  15. ADCC of cultured human melanoma cells: analysis with monoclonal antibodies to human melanoma-associated antigens.
    Scand J Immunol. 1981 Oct;14(4):369-77 PMID: 7336169
  16. Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells.
    Proc Natl Acad Sci U S A. 1982 Feb;79(4):1245-9 PMID: 6175965
  17. Directed effector cells selectively lyse human tumour cells.
    Nature. 1982 May 20;297(5863):234-6 PMID: 7078638
  18. Target-effector interactions in the rat natural killer cell system. I. The measurement of cytotoxicity at the single cell level.
    Eur J Immunol. 1982 Jun;12(6):457-63 PMID: 7117361
  19. IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.
    Proc Natl Acad Sci U S A. 1982 Aug;79(15):4761-5 PMID: 6289317
  20. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
    Cancer Res. 1983 Jan;43(1):422-9 PMID: 6600161
  21. A rapid technique for isolation of viable tumor cells from solid tumors: use of the tumor cells for induction and measurement of cell-mediated cytotoxic responses.
    Eur J Cancer Clin Oncol. 1982 Oct;18(10):991-1000 PMID: 6984388
  22. Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growth.
    Proc Natl Acad Sci U S A. 1983 Jan;80(2):529-33 PMID: 6572905
  23. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.
    N Engl J Med. 1982 Mar 4;306(9):517-22 PMID: 6173751
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1983-09-00
Pages
5407-11
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC384265
Subset
IM
Grants
NCI NIH HHS · CA28420 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com